Malheiro Luís, Lazzara Daniela, Xerinda Sandra, Pinheiro Maria Dolores, Sarmento António
Infectious Disease Department-Nephrology Research Development Unit (FCT-725), Faculty of Medicine, University of Porto, Centro Hospitalar São João, Porto, Portugal.
BMC Res Notes. 2014 Aug 26;7:566. doi: 10.1186/1756-0500-7-566.
Cryptococcal meningoencephalitis is an opportunistic infection that predominantly affects immunocompromised patients. Hyper immunoglobulin M syndrome is a primary immunodeficiency syndrome that increases susceptibility to several opportunistic infections. Here, we report a case of cryptococcal meningoencephalitis in the context of hyper immunoglobulin M syndrome, a situation that has been reported very few times and whose management is not clearly defined. We describe our management of this case and the outcome of the patient to help in future similar situations.
The patient is a 19-year-old Caucasian male student diagnosed with X-linked hyper immunoglobulin M syndrome and treated chronically with weekly intravenous immunoglobulin and daily sulfamethoxazole-trimethoprim. He was admitted to the infectious diseases ward because of headache, diplopia and a cerebral-spinal fluid analysis revealing cryptococcal meningoencephalitis. The patient was treated with liposomal amphotericin and flucytosine with a favorable outcome. Maintenance therapy with fluconazole has continued and will be sustained for 6 months following his upcoming bone marrow transplantation.
Monitoring for cryptococcal meningoencephalitis should be considered in patients with primary immunodeficiencies, as clinical manifestations may go unnoticed. In these patients, it is expected that chronic treatment with fluconazole will be the only treatment that will prevent reinfection or reactivation, and therefore should be kept at least until bone marrow transplant, the only curative treatment, is performed. It may, however, lead to intolerable side effects and hepatic toxicity.
隐球菌性脑膜脑炎是一种主要影响免疫功能低下患者的机会性感染。高免疫球蛋白M综合征是一种原发性免疫缺陷综合征,会增加对多种机会性感染的易感性。在此,我们报告一例高免疫球蛋白M综合征背景下的隐球菌性脑膜脑炎病例,这种情况报道极少,其治疗方法也未明确界定。我们描述了该病例的治疗过程及患者的预后情况,以帮助应对未来类似情况。
该患者是一名19岁的白种男性学生,被诊断为X连锁高免疫球蛋白M综合征,长期接受每周一次的静脉注射免疫球蛋白及每日一次的磺胺甲恶唑-甲氧苄啶治疗。他因头痛、复视而入住传染病病房,脑脊液分析显示为隐球菌性脑膜脑炎。患者接受了脂质体两性霉素和氟胞嘧啶治疗,预后良好。在即将进行骨髓移植后,继续使用氟康唑进行维持治疗,并将持续6个月。
对于原发性免疫缺陷患者,应考虑监测隐球菌性脑膜脑炎,因为其临床表现可能未被注意到。在这些患者中,预计长期使用氟康唑治疗将是预防再次感染或复发的唯一治疗方法,因此应至少持续至进行唯一的治愈性治疗——骨髓移植。然而,它可能会导致无法耐受的副作用和肝毒性。